Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension.

Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension.

3-Hydroxy-3-methylglutaryl-coenzyme A [HMG-CoA] reductase gene (Hmgcr) is a susceptibility gene for essential hypertension. Sequencing of the Hmgcr locus in genetically hypertensive BPH (blood pressure high), genetically hypotensive BPL (blood pressure low) and genetically normotensive BPN (blood pr...

Full description

Bibliographic Details
Main Authors:	Parshuram J Sonawane, Bhavani S Sahu, Binu K Sasi, Parimala Geedi, Govinda Lenka, Nitish R Mahapatra
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3031630?pdf=render

Similar Items

HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
by: Aronson, J, et al.
Published: (1990)

Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01)

The discovery and development of HMG-CoA reductase inhibitors.
by: A Endo
Published: (1992-11-01)

HMG CoA reductase of intestinal mucosa and liver of the rat
by: S. Shefer, et al.
Published: (1972-05-01)

HMG-CoA reductase is not the site of the primary defect in phytosterolemia
by: G.M.B. Berger, et al.
Published: (1998-05-01)

An Assessment of Oral Health in Hypertensive Patients Treated with HMG-CoA Reductase Inhibitors (Statins)
by: Amir AM Al-Joboury, et al.
Published: (2015-12-01)

Eupatilin Alleviates Hyperlipidemia in Mice by Inhibiting HMG-CoA Reductase
by: Kyung-Joo Kim, et al.
Published: (2023-01-01)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
by: Paolo Gelosa, et al.
Published: (2007-11-01)

Measurement of human leukocyte microsomal HMG-CoA reductase activity.
by: H J Harwood, Jr, et al.
Published: (1984-09-01)

Induction of HMG CoA reductase by the administration of 20,25-diazacholesterol
by: R Langdon, et al.
Published: (1977-01-01)

Diurnal variation of HMG CoA reductase activity in rat intestine
by: S. Shefer, et al.
Published: (1972-09-01)

Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
by: Noel Lorenzo Villalba, et al.
Published: (2021-06-01)

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
by: Marc M Schumacher, et al.
Published: (2015-03-01)

Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.
by: JJ Hwa, et al.
Published: (1992-05-01)

Inactivation of rat liver HMG-CoA reductase phosphatases by polycarboxylic acids.
by: F G Hegardt, et al.
Published: (1983-07-01)

Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in <i>Aspergillus fumigatus</i>?
by: Irene Gonzalez-Jimenez, et al.
Published: (2021-10-01)

Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase
by: Marco De Giorgi, et al.
Published: (2020-12-01)

Lepidopteran HMG-CoA reductase is a potential selective target for pest control
by: Yuan-mei Li, et al.
Published: (2017-01-01)

An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia
by: Diana S. Gesto, et al.
Published: (2020-08-01)

Molecular docking studies of Triphala with catalytic portion of HMG-CoA reductase enzyme
by: Prasoborn Rinthong, et al.
Published: (2023-04-01)

Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor
by: Sucharita Bose, et al.
Published: (2023-04-01)

Influence of simvA glyzin on expression and inhibition of hmg-coa reductase in rats liver
by: Yu. I. Ragino, et al.
Published: (2015-06-01)

Hesperidin Interaction with HMG-CoA-Reductase Enzyme in Hypercholesterolemia: A Study in Silico
by: Annisa Rizqi Dwi Oktaviani, et al.
Published: (2021-09-01)

Effects of HMG-CoA Reductase Inhibitors (Statins) On Bone Mineral Density and Metabolism
by: Nehir Samancı, et al.
Published: (2004-06-01)

Inhibitory effects on the HMG-CoA Reductase in the chemical constituents of the Cassia mimosoides Linn
by: Shen Chuangpeng, et al.
Published: (2016-12-01)

A second gene for peroxisomal HMG-CoA reductase? A genomic reassessment
by: Rainer Breitling, et al.
Published: (2002-12-01)

Abstracts. Regulation of HMG-CoA reductase. July 7, 1979, Toronto, Canada.
Published: (1979-11-01)

Comparison of the effect of two HMG CoA reductase inhibitors on LDL susceptibility to oxidation
by: Vera Lúcia Portal, et al.
Published: (2003-02-01)

Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
by: Johannes Kettunen, et al.
Published: (2019-12-01)

Abstracts. HMG-CoA reductase IV. August 24, 1985, Breukelen, The Netherlands.
Published: (1988-07-01)

Studies on the catalytic site of rat liver HMG-CoA reductase: interaction with CoA-thioesters and inactivation by iodoacetamide.
by: J Roitelman, et al.
Published: (1989-01-01)

Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based on the JAK/STAT pathway
by: Wen Yuan, et al.
Published: (2023-09-01)

ASSOCIATION OF POLYMORPHISM RS3846663 IN HMG-CoA REDUCTASE GENE WITH THE EFFECTIVENESS OF STATIN THERAPY IN PATIENTS WITH CORONARY HEART DISEASE
by: Aleksey Vladimirovich Osedko, et al.
Published: (2019-05-01)

Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
by: Shi-You Jiang, et al.
Published: (2018-12-01)

In silico analysis of Mentha pipertia (phyto-constituents) as HMG coa reductase and squalene synthase inhibitors
by: Narayanaswamy, Radhakrishnan, et al.
Published: (2018)

Peroxisomal Localization of a Truncated HMG-CoA Reductase under Low Cholesterol Conditions
by: Jianqiu Wang, et al.
Published: (2024-02-01)

Simvastatin: In Vitro Metabolic Profiling of a Potent Competitive HMG-CoA Reductase Inhibitor
by: Wencui Yin, et al.
Published: (2022-11-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research
by: Hun-Sung Kim, et al.
Published: (2017-02-01)

Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
by: Hongwen Chen, et al.
Published: (2022-07-01)